All filters
Slidesets
Is Baseline Resistance Testing Needed?- Ricardo Diaz, MD
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
Clinical Case Discussion 3- Dr. M.C.Rachid de Lacerda
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
The Role of HIV Integrase Inhibitors in PrEP & PEP- Richard Elion
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
HIV Integrase Inhibitors in an Aging Population (Polypharmacy - Comorbidities)- Dr. M.C.Rachid de Lacerda
Presented at:
Brazilian HIV Clinical Forum 2017
Slidesets
Clinical Case on Integrase Inhibitors Use in TB-Infected Patients- Dr. L. Grinsztejn
Presented at:
Brazilian HIV Clinical Forum 2017
Meeting
Global HIV Clinical Forum 2017
Slidesets
Basic Science of Integrase Inhibitors - Recent Advances- Francois Clavel, MD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Potential role of Integrase Inhibitors in resource-limited settings- Gary Maartens, MD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Resistance Characteristics of Integrase Inhibitors- Charlotte Charpentier, PharmD, PhD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Clinical Pharmacology related considerations- David Back, PhD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Pediatric use of Integrase Inhibitors- Mark Cotton, MD, PhD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Optimal Use of Integrase Inhibitors in Women- Sharon Walmsley, FRCPC, MD, MSC
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Mutations to Integrase inhibitors in real life- Dr. Isabel Viciana Ramos
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Clinical case of transmitted resistance to HIV Integrase Inhibitors- Dr. Carmen María González Domenech
Presented at:
Global HIV Clinical Forum 2017
Slidesets
The Role of Integrase Inhibitors during HIV prevention- Pep Coll, MD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Clinical Case -Reduced Drug Regimen- Pedro Cahn, MD, PhD
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Optimizing Clinical Utility of Integrase Inhibitors- Anton Pozniak, MD, FRCP
Presented at:
Global HIV Clinical Forum 2017
Slidesets
Latest Estimates for Pediatric/Adolescent HIV Prevalence and Coverage- Mary Mahy, ScD, MHSc
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
What Have We Learned from the ACT Initiative – identifying and treating children with HIV infection- George Siberry, MD, PhD
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
The Hidden Pediatric HIV Epidemic in Eastern Europe- Natella Rakhmanina, MD, PhD, FAAP, FCP, AAHIVS
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Debate: Integrase Inhibitor-based ART should be first-line therapy for children- Albert Faye, PhD
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Challenges and Triumphs of Pediatric HIV Care and Treatment in West/Central Africa- Didier Ekouevi, MD, PhD
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
Debate: Integrase Inhibitor-based ART should be first-line therapy for children- Victor Musiime, MBChB, MMED, PhD
Presented at:
International Workshop on HIV & Pediatrics 2017